Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases. 

Biotechnology

Q32 Bio

Jodie Morrison

Eric Bell

Reena Malik

Justin Rogers

Joel Scherer

Isidora Tošić

Hong Wu, MD, PhD, DABT

Fei Liu

Theresa Carbeau

Dessi McEntee, MS, DABT

Bill Lundberg

David Appugliese

Maria Marzilli

Jason Campagna

Shelia Violette

Finance & Strategic Planning

Scientific Research & Development

Leadership Team

Clinical Operations

Quality Assurance & Regulatory Affairs

Teams at Q32 Bio

Finance & Strategic Planning

Scientific Research & Development

Leadership Team

Clinical Operations

Quality Assurance & Regulatory Affairs